In vivo, JP could increase the levels of IL-2, IL-4, and IL-10 in the serum of mice treated with cyclophosphamide [49], increase the level of IL-2 in the serum of chronic fatigue (CFS) rats, and decrease the level of IL-10 [56]. The gene discussed is IL2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.